Literature DB >> 3954717

The effects of physostigmine and scopolamine on recognition memory in monkeys.

T G Aigner, M Mishkin.   

Abstract

The visual recognition of rhesus monkeys was evaluated by means of a delayed nonmatching-to-sample task with trial-unique objects. Each daily session consisted of two lists of 20 objects each, which untreated animals were able to recognize at approximately 75% accuracy. When they were performing at this level reliably, doses of physostigmine (0.32, 1.0, 3.2, 10.0, 32.0, 56.0 micrograms/kg), scopolamine (1.0, 3.2, 5.6, 10.0, 17.8, 32.0 micrograms/kg), or saline were administered 20 min prior to the session. Physostigmine and scopolamine produced dose-related increases and decreases, respectively, in the number of objects correctly remembered. The systematic changes in performance support the view that cholinergic mechanisms contribute to recognition memory and suggest that tasks with trial-unique objects may be particularly useful for studying the mnemonic effects of cholinergic drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954717     DOI: 10.1016/s0163-1047(86)80008-5

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  48 in total

1.  Simulations of the role of the muscarinic-activated calcium-sensitive nonspecific cation current INCM in entorhinal neuronal activity during delayed matching tasks.

Authors:  Erik Fransen; Angel A Alonso; Michael E Hasselmo
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Visual habit formation in monkeys with neurotoxic lesions of the ventrocaudal neostriatum.

Authors:  J Fernandez-Ruiz; J Wang; T G Aigner; M Mishkin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Effects of cholinergic deafferentation of the rhinal cortex on visual recognition memory in monkeys.

Authors:  Janita Turchi; Richard C Saunders; Mortimer Mishkin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 5.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 6.  Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback.

Authors:  Lisa M Giocomo; Michael E Hasselmo
Journal:  Mol Neurobiol       Date:  2007-07-20       Impact factor: 5.590

7.  Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques.

Authors:  T G Aigner; S J Mitchell; J P Aggleton; M R DeLong; R G Struble; D L Price; G L Wenk; K D Pettigrew; M Mishkin
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

8.  Double dissociation of pharmacologically induced deficits in visual recognition and visual discrimination learning.

Authors:  Janita Turchi; Deanne Buffalari; Mortimer Mishkin
Journal:  Learn Mem       Date:  2008-08-06       Impact factor: 2.460

9.  Scopolamine impairs auditory delayed matching-to-sample performance in monkeys.

Authors:  Bethany Plakke; Chi-Wing Ng; Amy Poremba
Journal:  Neurosci Lett       Date:  2008-04-10       Impact factor: 3.046

Review 10.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.